Content about BI Pharmaceuticals

January 17, 2013
Boehringer Ingelheim Pharmaceuticals starts phase-3 trial of HCV drug

Boehringer Ingelheim Pharmaceuticals has enrolled the first patients in its late-stage trial of a treatment for hepatitis C, the drug maker said Thursday.

September 18, 2012
BI launches Combivent Respimat

Boehringer Ingelheim Pharmaceuticals has launched a drug for treating chronic obstructive pulmonary disease, the company said Tuesday.

© 2013 Drug Store News. All Rights Reserved.